相关实验视频

Updated: Sep 20, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

哈萨克斯坦和蒙古的结核病负担趋势和差异 (2017-2021):使用GBD指标进行比较分析

Oyunzul Amartsengel¹, Malika Idayat², Alexander Rommel³

¹Department of Health Policy, Mongolian National University of Medical Science, Ulaanbaatar, Mongolia.

Frontiers in public health

|May 30, 2025

概括

2017-2021年期间,哈萨克斯坦和蒙古的结核病 (TB) 负担显著下降,生命损失和残疾年数显著减少. 蒙古在减少结核病死亡率和发病率方面仍然面临挑战,需要有针对性的干预措施.

科学领域:

流行病学流行病学
公共卫生公共卫生
全球健康全球健康

背景情况:

结核病 (TB) 是中亚的主要传染病,对个人和卫生系统造成重大负担.
结核病对全球的发病率和死亡率做出了重大贡献,每年导致超过一百万人的死亡.
评估结核病的影响对于了解全球卫生挑战至关重要.

研究的目的:

评估蒙古和哈萨克斯坦结核病 (TB) 负担的模式和变化.
利用全球疾病负担 (GBD) 框架分析结核病相关死亡率和发病率的趋势.

主要方法:

采用了回顾性横截面研究设计.
全球疾病负担 (GBD) 框架,利用残疾调整寿命年 (DALY),用于衡量疾病负担.
分析了2017年至2021年间蒙古和哈萨克斯坦国家结核病登记数据.

主要成果:

哈萨克斯坦从2017年到2021年,失去了生命年数 (YLL) 减少了18.2%,残疾生活年数 (YLD) 减少了36%.
在同一时期,蒙古的YLL下降了24.9%,YLD下降了39.4%.
这两个国家都显示出结核病总体负担的显著降低,由下降的DALY,YLL和YLD率表明.

结论:

结核病控制工作在哈萨克斯坦和蒙古取得了积极成果,疾病负担大幅减少.
蒙古在减少与结核病相关的死亡率和发病率方面面临着持续的挑战,特别是在老年男性中,需要有针对性的干预措施.
维持结核病控制需要解决医疗保健公平问题,改善获得服务的机会,并了解区域差异.

关键词:

中亚的中亚地区.这就是为什么TBTBTBTB 根据残疾调整的寿命年数.多年来生活在残疾中.失去了生命的岁月.

更多相关视频

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Prevalence and Incidence

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...